KGET Stock Overview
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CaliPharms, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -99.00% |
| 5 Year Change | 0% |
| Change since IPO | -99.98% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| KGET | US Machinery | US Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 1.0% |
| 1Y | 0% | 27.9% | 21.9% |
Return vs Industry: KGET underperformed the US Machinery industry which returned 32.3% over the past year.
Return vs Market: KGET underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| KGET volatility | |
|---|---|
| KGET Average Weekly Movement | n/a |
| Machinery Industry Average Movement | 4.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KGET's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KGET's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Eric Watson | n/a |
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017.
CaliPharms, Inc. Fundamentals Summary
| KGET fundamental statistics | |
|---|---|
| Market cap | US$13.88k |
| Earnings (TTM) | -US$6.31m |
| Revenue (TTM) | US$112.47k |
0.0x
P/S Ratio0.0x
P/E RatioIs KGET overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KGET income statement (TTM) | |
|---|---|
| Revenue | US$112.47k |
| Cost of Revenue | US$143.03k |
| Gross Profit | -US$30.57k |
| Other Expenses | US$6.28m |
| Earnings | -US$6.31m |
Last Reported Earnings
Sep 30, 2014
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did KGET perform over the long term?
See historical performance and comparison